Envista Holdings Corporation (NVST)
NYSE: NVST · Real-Time Price · USD
23.66
+0.06 (0.25%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Envista Holdings Revenue
Envista Holdings had revenue of $730.50M in the quarter ending July 3, 2026, with 7.10% growth. This brings the company's total for the last twelve months to $2.86B, up 11.89% year-over-year. In the year 2025, Envista Holdings had annual revenue of $2.72B with 8.32% growth. That makes Envista Holdings the 3,939th largest company in the world by revenue and 1,080th in the United States.
Revenue (ttm)
$2.86B
Revenue Growth
+11.89%
P/S Ratio
1.33
Revenue / Employee
$238,042
Employees
12,000
Market Cap
3.80B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Envista Holdings breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.72B | 208.90M | 8.32% |
| Dec 31, 2024 | 2.51B | -55.90M | -2.18% |
| Dec 31, 2023 | 2.57B | -2.60M | -0.10% |
| Dec 31, 2022 | 2.57B | 60.20M | 2.40% |
| Dec 31, 2021 | 2.51B | 579.80M | 30.06% |
| Dec 31, 2020 | 1.93B | -355.70M | -15.57% |
| Dec 31, 2019 | 2.28B | -559.70M | -19.68% |
| Dec 31, 2018 | 2.84B | 33.60M | 1.20% |
| Dec 31, 2017 | 2.81B | 25.50M | 0.92% |
| Dec 31, 2016 | 2.79B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bausch + Lomb | 5.32B |
| DENTSPLY SIRONA | 3.64B |
| MiniMed Group | 3.22B |
| Teleflex | 2.25B |
| ICU Medical | 2.16B |
| Merit Medical Systems | 1.58B |
| Stevanato Group | 1.40B |
| Warby Parker | 911.61M |
NVST News
- 11 days ago - Envista downgraded to Neutral from Outperform at Baird - TheFly
- 12 days ago - Envista price target lowered to $32 from $35 at Leerink - TheFly
- 17 days ago - Envista price target lowered to $26 from $28 at Piper Sandler - TheFly
- 20 days ago - Envista Schedules Third Quarter 2026 Earnings Call - PRNewsWire
- 4 weeks ago - Envista price target lowered to $26 from $29 at BMO Capital - TheFly
- 5 weeks ago - Envista price target lowered to $27 from $30 at UBS - TheFly
- 5 weeks ago - Envista Holdings Transcript: Investor Day 2026 - Transcripts
- 5 weeks ago - Envista Holdings Slides: FY 2026 - Filings